Findings from a new genome study could enhance current pathology methods in endometrial cancer and help discern types of endometrial tumors.
Abnormal Pap results usually should be followed up with a DNA-based test rather than with another cervical smear, a study indicates.
A two-step immunotherapy approach and the experimental antibody-drug conjugate DMUC5754A show promise for advanced ovarian cancer, according to research presented at AACR 2013.
Breast cancer risk highest risk among women who initiate hormone treatment closer to menopause.
The best HPV screening programs maximize high-grade lesion detection without excessive testing.
Shift work may be associated with an increased risk of ovarian cancer, according to a study published in the April issue of Occupational & Environmental Medicine.
Revisions to cervical cancer protocols may hinder clinicians diagnosing younger women with AIS
IP chemo improves long-term survival in advanced disease versus intravenous therapy
Women with Lynch syndrome and endometrial cancer have elevated risks for several other cancers, including breast, bladder, and kidney cancers.
Bevacizumab plus chemotherapy improved survival in women with advanced, recurrent, or persistent cervical cancer, according to interim findings.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|